You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰凌醫藥(01011.HK)年度淨虧損收窄至54.2萬元,毛利率升至64.8%
格隆匯 04-01 01:38

格隆匯4月1日丨泰凌醫藥(01011.HK)公佈未經審核全年業績,截至2021年12月31日止12個月,公司收益為2.27億元人民幣,同比增長2.24%;公司權益持有人應占虧損為54.2萬元,上年同期虧損3.58億元;每股虧損0.03分。

於截至2021年12月31日止年度,毛利增加人民幣1210萬元至人民幣1.47億元,相比2020年同期則為人民幣1.35億元。截至2021年12月31日止年度,毛利率上升4個百分點至64.8%,相比2020年同期則為60.8%。毛利率的上升主要由於較高毛利率的產品如舒思的銷售貢獻因銷售模式及業務合作伙伴變動而增加,導致相關高毛利的產品收益上升所致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account